Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

522
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
522

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment tools for differential diagnosis of neglect: Focusing on egocentric neglect and allocentric neglect.

World journal of clinical cases·2022
Same author

Non-Deep Simple Morphophysiological Dormancy and Germination Characteristics of <i>Gentiana triflora</i> var. <i>japonica</i> (Kusn.) H. Hara (Gentianaceae), a Rare Perennial Herb in Korea.

Plants (Basel, Switzerland)·2021
Same author

Image Registration of <sup>18</sup>F-FDG PET/CT Using the MotionFree Algorithm and CT Protocols through Phantom Study and Clinical Evaluation.

Healthcare (Basel, Switzerland)·2021
Same author

A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease.

Pharmaceutics·2021
Same author

Chiral differentiation of d- and l-alanine by permethylated β-cyclodextrin: IRMPD spectroscopy and DFT methods.

Physical chemistry chemical physics : PCCP·2017
Same journal

RETRACTED: Zhang et al. A Novel Framework for Reconstruction and Imaging of Target Scattering Centers via Wide-Angle Incidence in Radar Networks. <i>Sensors</i> 2025, <i>25</i>, 6802.

Sensors (Basel, Switzerland)·2026
Same journal

Enhancing Unsupervised Multi-Source Domain Adaptation for Person Re-Identification via Mixture of Experts and Graph-Based Relation.

Sensors (Basel, Switzerland)·2026
Same journal

Development of an Instrumented Glove for Palmar Pressure Assessment in Kayakers.

Sensors (Basel, Switzerland)·2026
Same journal

Development and Experimental Validation of an Autonomous IoT-Based Monitoring System for Real-Time Water Quality Assessment in the Amazon River.

Sensors (Basel, Switzerland)·2026
Same journal

Semi-Supervised Adversarial Learning Framework for Controller Area Network Bus Intrusion Detection.

Sensors (Basel, Switzerland)·2026
Same journal

Smart Optimization Method for Safety Signs in Innovative Manufacturing Environments Integrating Industrial Field IoT Sensors and Knowledge Graphs.

Sensors (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jul 20, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

255

Classification of Alzheimer's Progression Using fMRI Data.

Ju-Hyeon Noh1, Jun-Hyeok Kim1, Hee-Deok Yang1

  • 1Department of Computer Engineering, University of Chosun, Gwangju 61452, Republic of Korea.

Sensors (Basel, Switzerland)
|July 29, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a deep learning model using 4D functional magnetic resonance imaging (fMRI) to accurately diagnose Alzheimer's disease progression. The novel 3D-CNN-LSTM approach achieves 96.4% accuracy, offering a promising tool for early detection.

Keywords:
3D U-NetAlzheimer’s diseasedeep learning

More Related Videos

A Free-breathing fMRI Method to Study Human Olfactory Function
10:42

A Free-breathing fMRI Method to Study Human Olfactory Function

Published on: July 30, 2017

9.7K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI&#8212;Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K

Related Experiment Videos

Last Updated: Jul 20, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

255
A Free-breathing fMRI Method to Study Human Olfactory Function
10:42

A Free-breathing fMRI Method to Study Human Olfactory Function

Published on: July 30, 2017

9.7K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI&#8212;Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Functional magnetic resonance imaging (fMRI) has advanced brain research over three decades.
  • Deep learning models show promise in various complex data analysis tasks.

Purpose of the Study:

  • To develop and evaluate a deep learning model for diagnosing Alzheimer's disease (AD) progression.
  • To classify individuals into categories: condition normal (CN), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI), and AD.

Main Methods:

  • A 4D fMRI dataset was pre-processed in four steps to remove noise.
  • A 3D-CNN-LSTM classification model was employed, utilizing U-Net for spatial feature extraction and LSTM for temporal feature extraction.
  • Comparative experiments involved training three models with adjusted time dimensions.

Main Results:

  • The proposed 3D-CNN-LSTM model achieved an average accuracy of 96.4% using five-fold cross-validation.
  • The model effectively extracted both spatial and temporal features from fMRI data.
  • The method demonstrated high potential in identifying Alzheimer's disease progression.

Conclusions:

  • The developed 3D-CNN-LSTM model shows significant potential for the early identification and diagnosis of Alzheimer's disease progression using 4D fMRI data.
  • This approach offers a non-invasive method for monitoring cognitive decline and disease staging.